{"id":1046,"date":"2026-05-18T08:53:10","date_gmt":"2026-05-18T13:53:10","guid":{"rendered":"https:\/\/portaltowellness.net\/?post_type=product&#038;p=1046"},"modified":"2026-11-02T17:26:06","modified_gmt":"2026-11-02T23:26:06","slug":"retatrutide-60mg-research-use-only","status":"publish","type":"product","link":"https:\/\/portaltowellness.net\/es\/shop\/retatrutide-60mg-research-use-only\/","title":{"rendered":"Retatrutida \u2013 60mg\/vial \u2014 Solo para uso en investigaci\u00f3n"},"content":{"rendered":"<div class=\"ptw-coa-published\" style=\"border: 1px solid #cfe8d6; border-left: 4px solid #2e8b57; background: #f4fbf6; border-radius: 8px; padding: 14px 18px; margin: 0 0 20px; font-size: 15px; line-height: 1.6;\">\r\n<p style=\"margin: 0 0 6px;\"><strong>Resultado de laboratorio independiente \u00b7 lote PTW-Reta60-2608-001<\/strong><\/p>\r\n<p style=\"margin: 0 0 8px;\">Retatrutida 60mg. Probado por Janoshik Analytical (tarea #239839), an\u00e1lisis realizado el 7 de oct de 2026. La muestra fue tomada de nuestro propio inventario, enviada y pagada por Portal to Wellness, y el informe nos identifica como el cliente.<\/p>\r\n<ul style=\"margin: 0 0 8px 18px;\">\r\n<li>Identidad: retatrutida, confirmada mediante prueba ciega<\/li>\r\n<li>Contenido medido: 64.59 mg por vial (etiquetado como 60 mg)<\/li>\r\n<li>Pureza: 99.725% (HPLC)<\/li>\r\n<\/ul>\r\n<p style=\"margin: 0;\"><a href=\"https:\/\/verify.janoshik.com\/tests\/239839-Retatrutide_60mg_WC5I8EVRTF6R\" target=\"_blank\" rel=\"noopener nofollow\">Ver y verificar el informe completo en el sitio de Janoshik \u2192<\/a><\/p>\r\n<p style=\"margin: 6px 0 0; font-size: 13px; color: #555;\">Este resultado corresponde al lote PTW-Reta60-2608-001, el lote que se est\u00e1 enviando actualmente. El n\u00famero de lote est\u00e1 impreso en la etiqueta del vial. Consulta todos los resultados publicados en nuestra <a href=\"\/es\/lab-verification-quality-testing\/\">Pruebas de laboratorio y Verificaci\u00f3n<\/a> p\u00e1gina.<\/p>\r\n<\/div>\r\n<p><\/p>\r\n<p><style>.ptw-product-research-link{background:#f6f3ec;border:1px solid #e0d9c8;border-left:4px solid #8a7a4d;border-radius:8px;padding:14px 18px;margin:16px 0 20px;font-size:15px;}.ptw-product-research-link__label{display:block;font-size:11px;font-weight:700;letter-spacing:.08em;text-transform:upp<span data-mce-type=\"bookmark\" style=\"display: inline-block;width: 0px;overflow: hidden;line-height: 0\" class=\"mce_SELRES_start\">\ufeff<\/span>ercase;color:#8a7a4d;margin-bottom:6px;}.ptw-product-research-link__link{display:block;color:#1a2b4c;font-weight:600;text-decoration:underline;margin-top:3px;}<\/style><\/p>\r\n<p><br \/><\/p>\r\n<div class=\"ptw-product-research-link\"><span class=\"ptw-product-research-link__label\">Respaldado por la investigaci\u00f3n<\/span><a class=\"ptw-product-research-link__link\" href=\"https:\/\/portaltowellness.net\/es\/research\/glp1-adjunct-peptide-research-guide\/\">Leer: C\u00f3mo los compuestos del eje incretina y hormona de crecimiento en la literatura \u2192<\/a><\/div>\r\n<p><br \/>Retatrutida (LY3437943) es un novedoso agonista triple unimolecular que act\u00faa simult\u00e1neamente en tres v\u00edas de receptores: p\u00e9ptido similar al glucag\u00f3n tipo 1 (GLP-1), polip\u00e9ptido insulinotr\u00f3pico dependiente de glucosa (GIP) y receptores de glucag\u00f3n. Este mecanismo de triple receptor la distingue de los agonistas duales y los compuestos de agonista \u00fanico disponibles actualmente para investigaci\u00f3n.<\/p>\r\n<h3>Fase de desarrollo<\/h3>\r\n<p>Retatrutida es un compuesto en investigaci\u00f3n en desarrollo cl\u00ednico de Fase 3. Los resultados de los ensayos reportados por el patrocinador se resumen con fuentes en la Biblioteca de investigaci\u00f3n, no aqu\u00ed \u2014 las p\u00e1ginas de producto de este sitio no incluyen datos de eficacia cl\u00ednica.<\/p>\r\n<p><a href=\"https:\/\/portaltowellness.net\/es\/research\/retatrutide-phase-3-triumph-1-results-2\/\">Resultados de Fase 3 TRIUMPH-1 de Retatrutida, revisados \u2192<\/a><\/p>\r\n<h3>Estado regulatorio<\/h3>\r\n<p>Retatrutida no est\u00e1 aprobada por la FDA ni por ning\u00fan organismo regulador para ning\u00fan uso. No es componente de ning\u00fan medicamento aprobado y no es elegible para la elaboraci\u00f3n en farmacia bajo la secci\u00f3n 503A o 503B de la FD&amp;C Act. Suministrada para <strong>solo para uso en investigaci\u00f3n<\/strong> \u2014 no para uso humano ni veterinario.<\/p>\r\n<div class=\"ptw-research-library\" style=\"background: #f8f9fa; border-left: 3px solid #2e7d32; padding: 16px 20px; margin-top: 24px; border-radius: 4px;\">\r\n<p style=\"margin: 0 0 8px; font-weight: 600; font-size: 14px; text-transform: uppercase; letter-spacing: .05em; color: #2e7d32;\">Biblioteca de investigaci\u00f3n<\/p>\r\n<ul style=\"margin: 0; padding-left: 20px;\">\r\n<li><a href=\"\/es\/research\/glp1-biological-aging-epigenetic-research\/\">Agonistas del receptor GLP-1 y envejecimiento biol\u00f3gico: lo que muestra la investigaci\u00f3n<\/a><\/li>\r\n<li><a href=\"\/es\/research\/injectable-vs-oral-glp1-what-researchers-need-to-know\/\">GLP-1 Inyectable vs. Oral: Lo que los Investigadores Necesitan Saber<\/a><\/li>\r\n<li><a href=\"https:\/\/portaltowellness.net\/es\/research\/retatrutide-phase-3-triumph-1-results-2\/\">Resultados de la Fase 3 TRIUMPH-1 de Retatrutida: hallazgos clave para investigadores<\/a><\/li>\r\n<li><a href=\"https:\/\/portaltowellness.net\/es\/research\/retatrutide-vs-tirzepatide-triumph-phase-3\/\">Retatrutida vs. Tirzepatida: Lo que los datos de la Fase 3 TRIUMPH-1 muestran a los investigadores<\/a><\/li>\r\n<li><a href=\"https:\/\/portaltowellness.net\/es\/research\/preserving-lean-mass-glp-1-semalean-data\/\">Preservaci\u00f3n de masa magra durante la investigaci\u00f3n con GLP-1: lo que mostraron los datos de SEMALEAN<\/a><\/li>\r\n<li><a href=\"https:\/\/portaltowellness.net\/es\/research\/glp-1-prior-authorization-data\/\">Datos de Autorizaci\u00f3n Previa de GLP-1<\/a><\/li>\r\n<li><a href=\"https:\/\/portaltowellness.net\/es\/research\/retatrutide-expanded-access\/\">Acceso Expandido a Retatrutida, Explicado<\/a><\/li>\r\n<li><a href=\"https:\/\/portaltowellness.net\/es\/research\/is-retatrutide-legal-2026\/\">\u00bfEs legal la retatrutida en 2026? Estado en la FDA y demandas contra Lilly<\/a><\/li>\r\n<li><a href=\"https:\/\/portaltowellness.net\/es\/research\/glp-1-cancer-risk-what-trials-show\/\">Riesgo de c\u00e1ncer con GLP-1: lo que muestran los ensayos<\/a><\/li>\r\n<li><a href=\"https:\/\/portaltowellness.net\/es\/research\/glp-1-mood-research-what-trials-show\/\">GLP-1 Mood Research: What Trials Show<\/a><\/li>\r\n<li><a href=\"https:\/\/portaltowellness.net\/es\/research\/real-world-glp-1-outcomes-vs-trials\/\">Resultados reales de GLP-1 vs resultados de ensayos cl\u00ednicos<\/a><\/li>\r\n<\/ul>\r\n<\/div>\r\n<p><em>Solo para uso en investigaci\u00f3n. No destinada a uso humano ni veterinario.<\/em><\/p>\r\n<p><style>.ptw-cmp-wrap{max-width:720px;margin:32px auto;font-family:-apple-system,BlinkMacSystemFont,\"Segoe UI\",Arial,sans-serif;color:#e2e8f0;}.ptw-cmp-wrap h3{font-size:20px;font-weight:700;color:#fff;margin-bottom:6px;}.ptw-cmp-wrap .ptw-cmp-sub{font-size:14px;color:#94a3b8;margin-bottom:16px;line-height:1.5;}.ptw-cmp-table{width:100%;border-collapse:collapse;background:#0d1f3c;border:1px solid #1e3a5f;border-radius:8px;overflow:hidden;font-size:14px;}.ptw-cmp-table th{background:#07111f;color:#64748b;text-transform:uppercase;letter-spacing:0.5px;font-size:11px;font-weight:700;padding:12px 14px;text-align:left;border-bottom:1px solid #1e3a5f;}.ptw-cmp-table td{padding:12px 14px;border-bottom:1px solid #1e3a5f;color:#e2e8f0;}.ptw-cmp-table tr:last-child td{border-bottom:none;}.ptw-cmp-table tr.ptw-highlight td{background:#112240;}.ptw-cmp-table .ptw-badge{display:inline-block;background:linear-gradient(135deg,#8A6500,#a67c00);color:#fff;font-size:10px;font-weight:700;letter-spacing:0.5px;text-transform:uppercase;padding:2px 8px;border-radius:10px;margin-left:6px;}.ptw-cmp-note{background:#112240;border:1px solid #1e3a5f;border-left:3px solid #7c3aed;border-radius:0 6px 6px 0;padding:14px 18px;margin-top:16px;font-size:13px;color:#94a3b8;line-height:1.6;}.ptw-cmp-note strong{color:#e2e8f0;}<\/style><\/p>\r\n<div class=\"ptw-cmp-wrap\">\r\n<h3>Comparar tama\u00f1os de Retatrutida<\/h3>\r\n<p class=\"ptw-cmp-sub\">Los tres son el mismo compuesto en diferentes tama\u00f1os de vial. El precio por mg disminuye conforme aumenta el tama\u00f1o.<\/p>\r\n<table class=\"ptw-cmp-table\">\r\n<tbody>\r\n<tr>\r\n<th>Producto<\/th>\r\n<th>Concentraci\u00f3n<\/th>\r\n<th>Precio<\/th>\r\n<th>Precio \/ mg<\/th>\r\n<\/tr>\r\n<tr>\r\n<td>Retatrutida 30mg<\/td>\r\n<td>30mg\/vial<\/td>\r\n<td>$169.00<\/td>\r\n<td>$5.63<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>Retatrutida 50mg<\/td>\r\n<td>50mg\/vial<\/td>\r\n<td>$199.00<\/td>\r\n<td>$3.98<\/td>\r\n<\/tr>\r\n<tr class=\"ptw-highlight\">\r\n<td>Retatrutida 60mg<span class=\"ptw-badge\">El m\u00e1s bajo $\/mg<\/span><\/td>\r\n<td>60mg\/vial<\/td>\r\n<td>$219.00<\/td>\r\n<td>$3.65<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Retatrutida es un agonista triple en investigaci\u00f3n que act\u00faa sobre los receptores GIP, GLP-1 y glucag\u00f3n. No est\u00e1 aprobada por la FDA ni por ning\u00fan otro organismo regulador y se suministra estrictamente para investigaci\u00f3n en laboratorio y fines de identificaci\u00f3n. No es para uso humano ni veterinario.<\/p>","protected":false},"featured_media":1136,"comment_status":"open","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ptw_protocol_fit":"","ptw_why_this":"","ptw_coa_url":"","ptw_science_overview":"","ptw_science_research":"","ptw_science_stack":"","_ptw_batch_number":"PTW-Reta60-2608-001"},"product_brand":[35],"product_cat":[520],"product_tag":[287,429,430,401],"class_list":["post-1046","product","type-product","status-publish","has-post-thumbnail","product_brand-portal-to-wellness","product_cat-metabolic-research","product_tag-glp-1","product_tag-injectable","product_tag-research","product_tag-triple-agonist","desktop-align-left","tablet-align-left","mobile-align-left","first","instock","sale","taxable","shipping-taxable","purchasable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/portaltowellness.net\/es\/wp-json\/wp\/v2\/product\/1046","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/portaltowellness.net\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/portaltowellness.net\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/portaltowellness.net\/es\/wp-json\/wp\/v2\/comments?post=1046"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/portaltowellness.net\/es\/wp-json\/wp\/v2\/media\/1136"}],"wp:attachment":[{"href":"https:\/\/portaltowellness.net\/es\/wp-json\/wp\/v2\/media?parent=1046"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/portaltowellness.net\/es\/wp-json\/wp\/v2\/product_brand?post=1046"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/portaltowellness.net\/es\/wp-json\/wp\/v2\/product_cat?post=1046"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/portaltowellness.net\/es\/wp-json\/wp\/v2\/product_tag?post=1046"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}